Shielded Bioactive Glass Scaffolds for Bone Tissue Regeneration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current porous bioactive glass scaffolds face challenges due to low strength, poor handleability, rapid crystallization, and slow conversion to hydroxyapatite, limiting their clinical use for tissue repair and regeneration.

Innovation Solution

A shielded glass scaffold is created by forming a mixture of bioactive glass fibers and beads into sintered agglomerates, then encasing them in a fused glass shield through a propane/oxygen flame treatment, enhancing strength and flowability while maintaining porosity for tissue growth.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If porous bioactive glass scaffolds are made to be highly porous for tissue penetration, then tissue growth capability is improved, but mechanical strength deteriorates

Engineering Contradiction:
Improvetissue penetration capabilityVSAvoidmechanical strength
Core Design Contradiction:
Adaptability or versatilityVSStrength

Solution Approach 1:

The scaffold structure employs local quality by creating regions of different porosity and density. The interconnected pore network provides tissue penetration in specific regions, while denser struts and nodes maintain mechanical strength in load-bearing areas. This spatial variation in structural properties allows simultaneous optimization of both tissue growth capability and mechanical strength.

Inventive Principle:
Principle #3Local quality

2Productivity

If porous scaffolds are made with high surface area for fluid reaction, then conversion to hydroxyapatite is accelerated, but handleability deteriorates

Engineering Contradiction:
Improveconversion rate to hydroxyapatiteVSAvoidhandleability
Core Design Contradiction:
ProductivityVSEase of operation

Solution Approach 1:

The scaffold incorporates a flexible polymer coating or shell that provides external structural support and protection during handling. This thin film layer does not significantly reduce the internal surface area available for fluid reaction, thus maintaining high conversion rates to hydroxyapatite while improving handleability and preventing scaffold breakage during surgical procedures.

Inventive Principle:
Principle #30Flexible shells and thin films

3Strength

If silicate glass is heated above glass transition temperature for viscous sintering, then bonding is improved, but crystallization occurs rapidly making the process difficult

Engineering Contradiction:
Improvebonding strengthVSAvoidsintering process control
Core Design Contradiction:
StrengthVSEase of manufacture

Solution Approach 1:

The sintering process utilizes parameter changes by precisely controlling temperature, time, and atmospheric conditions during heating above the glass transition temperature. The process parameters are optimized to achieve adequate viscous flow for bonding while minimizing the time spent in the crystallization zone, thus preventing excessive crystallization. Rapid heating and controlled cooling rates further manage the phase transformation kinetics.

Inventive Principle:
Principle #35Parameter changes

4Strength

If large glass particles (>500μm) are used to maintain structural integrity, then strength is improved, but conversion to hydroxyapatite takes years

Engineering Contradiction:
Improvestructural integrityVSAvoidconversion time to hydroxyapatite
Core Design Contradiction:
StrengthVSLoss of time

Solution Approach 1:

The scaffold structure is segmented into a hierarchical architecture where larger particles or struts provide structural integrity at the macro level, while interconnected pores and smaller surface features provide extensive surface area for fluid reaction. This segmentation allows large particles to maintain strength while the high surface-area-to-volume ratio of the overall porous structure accelerates hydroxyapatite conversion by enabling simultaneous reaction at multiple sites.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The shielded scaffold increases strength and handleability while promoting tissue growth and rapid conversion to hydroxyapatite, addressing the limitations of existing porous bioactive glass scaffolds for clinical applications.

Implementation Method 1

dropping the sintered agglomerate through a propane/oxygen flame at a temperature between 1982 °C and 2815 °C (3600°F and 5100°F)

Methodology Applied
Scientific EffectFlame heating: Combustion

Implementation Method 2

forming a fused periphery around a center of loose glass fibers and glass beads

Methodology Applied
Scientific EffectMelting: Melting

Implementation Method 3

Glasses with compositions similar to 45S5 and S53P4 crystallize rapidly when heated above each glasses respective glass transition temperature (T g ), making viscous sintering by traditional heat treatments difficult

Methodology Applied
Scientific EffectViscous sintering: Sintering

Data Source

PatentEP2984047B1Bioactive glass scaffolds, and method of making
Publication Date: 2022.06.15 MO-SCI CORP
  • EP2984047B1 patent drawingFigure 1~2
  • EP2984047B1 patent drawingFigure 3~4
  • EP2984047B1 patent drawingFigure 5~6

AI summary

A glass, glass-ceramic, or ceramic bead is described, with an internal porous scaffold microstructure that is surrounded by an amorphous shield. The shield serves to protect the internal porous microstructure of the shield while increasing the overall strength of the porous microstructure and improve the flowability of the beads either by themselves or in devices such as biologically degradable putty that, would be used in bone or soft tissue augmentation or regeneration. The open porosity present inside the bead will allow for enhanced degradability in-vivo as compared to solid particles or spheres and also promote the growth of tissues including but not limited to all types of bone, soft tissue, blood vessels, and nerves.